Precision Medicine Towards Individualized Dosing in Pediatric Rheumatology

被引：2
作者：
Balevic, Stephen J. [1 ,2 ]
Sagcal-Gironella, Anna Carmela P. [3 ,4 ,5 ]
机构：
[1] Duke Univ, Dept Pediat, Durham, NC 27710 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Hackensack Meridian Sch Med, Dept Pediat, Nutley, NJ USA
[4] Joseph M Sanzari Childrens Hosp, Div Pediat Rheumatol, 30 Prospect Ave,WFAN 3rd Floor, Hackensack, NJ 07601 USA
[5] K Hovnanian Childrens Hosp, Neptune, NJ USA
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2022年 / 48卷 / 01期
基金：
美国国家卫生研究院;
关键词：
Precision medicine; Pharmacokinetics; Therapeutics; Clinical pharmacology; DMARDs; JUVENILE IDIOPATHIC ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE-TRANSFORMYLASE; POPULATION PHARMACOKINETIC ANALYSIS; LOW BLOOD-CONCENTRATION; MYCOPHENOLIC-ACID; DISEASE-ACTIVITY; HYDROXYCHLOROQUINE CONCENTRATION; METHOTREXATE POLYGLUTAMATES; GENE POLYMORPHISMS;
D O I：
10.1016/j.rdc.2021.09.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：305 / 330
页数：26
相关论文
共 124 条
  • [1] ALBERTIONI F, 1995, EUR J CLIN PHARMACOL, V47, P507
  • [2] [Anonymous], 2018, PRODUCT INFORM ETANE
  • [3] [Anonymous], 2013, Table of pharmacogenomic biomarkers in drug labeling
  • [4] [Anonymous], 2020, PRODUCT INFORM CANAK
  • [5] [Anonymous], 2018, PRODUCT INFORM ADALI
  • [6] [Anonymous], 2019, PRODUCT INFORM CODEI
  • [7] [Anonymous], 2014, GEN CLIN PHARM CONS
  • [8] Use of Pharmacogenetics, Enzymatic Phenotyping, and Metabolite Monitoring to Guide Treatment with Azathioprine in Patients with Systemic Lupus Erythematosus
    Askanase, Anca D.
    Wallace, Daniel J.
    Weisman, Michael H.
    Tseng, Chung-E
    Bernstein, Lana
    Belmont, H. Michael
    Seidman, Ernest
    Ishimori, Mariko
    Izmirly, Peter M.
    Buyon, Jill P.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (01) : 89 - 95
  • [9] Balbi V, 2020, ARTHRITIS RHEUMATOL, V72
  • [10] Balevic SJ, 2021, CHILDHOOD ARTHRITIS
12345678910